Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
2021 · New England Journal of Medicine · 3,052 citations
https://doi.org/10.1056/nejmoa2108891
K
Kevin Brown
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
423
Papers
25.0K
Citations
75
h-index
236
i10-index
Kevin Brown is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Parvovirus B19 Infection Studies & SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies. The author has an h-index of 75, co-authored 360 publications.
ORCID: 0000-0002-1568-683XPapers by this author
worksAdeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors
2000 · Journal of General Virology · 131 citations
https://doi.org/10.1099/0022-1317-81-8-2077
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
2023 · Nature Medicine · 124 citations
https://doi.org/10.1038/s41591-023-02414-4
Challenges of measles and rubella laboratory diagnostic in the era of elimination
2017 · Clinical Microbiology and Infection · 91 citations
https://doi.org/10.1016/j.cmi.2017.04.009
The Interaction of Heparin Sulfate and Adeno-Associated Virus 2
2000 · Virology · 78 citations
https://doi.org/10.1006/viro.2000.0205
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
2021 · Immunity & Ageing · 73 citations
https://doi.org/10.1186/s12979-021-00246-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat